
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Tayar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Rheumatology, 2002 - 2004
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1998 - 2002
St Joseph's University Medical SchoolClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2027
AL State Medical License 2023 - 2026
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 1 citationsManaging Rheumatoid Arthritis in Older Adults with Cancer.Maria A Lopez-Olivo, Aliza R Karpes Matusevich, Jean H Tayar, Huifang Lu
Drugs & Aging. 2025-07-01 - 1 citationsAuthor Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar
Nature Communications. 2024-07-04 - Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL.Yuanteng Jeff Li, Victor G Prieto, Jean Tayar
RMD Open. 2023-11-27
Authored Content
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
- Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
Press Mentions
Metastatic Melanoma Survivor Finds Hope in Clinical TrialsAugust 20th, 2019
After My Acute Myeloid Leukemia Treatment, Check-Ups Feel like a ReunionJuly 30th, 2019
LupusMarch 18th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:












